Schedule 13D ownership disclosure
CHINOOK THERAPEUTICS INC
Security class unavailable · CUSIP: 16961L106
Event date: 2020-10-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,161,888
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-067095
- Form type
- SC 13D
- Filer
- CHINOOK THERAPEUTICS, INC.
- CIK
- CIK 1435049
- Filed
- Jun 01, 2022
- Reporting period
- Oct 05, 2020
- Description
- Schedule 13D beneficial ownership